EGFR antibody (AA 985-996)
Quick Overview for EGFR antibody (AA 985-996) (ABIN6937127)
Target
See all EGFR AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 985-996
-
Purpose
- EGFR (Epidermal Growth Factor Receptor) Antibody
-
Specificity
- This MAb recognizes a protein of 170 kDa, identified as EGFR. EGFR is type I receptor tyrosine kinase with sequence homology to erbB-1, -2, -3 -4 or HER-1, -2, -3 -4. It binds to Epidermal Growth Factor (EGF), Transforming Growth Factor-a (TGF-a), Heparin-binding EGF (HB-EGF), amphiregulin, betacellulin and epiregulin. EGFR is overexpressed in tumors of breast, brain, bladder, lung, gastric, head neck, esophagus, cervix, vulva, ovary, and endometrium. It is predominantly present in squamous cell carcinomas.
-
Cross-Reactivity (Details)
- Human.
-
Purification
- 200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- A synthetic peptide corresponding to aa 985-996 of human EGFR
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
-
Known_Application: Western Blot (1-2 μg/mL), Optimal dilution for a specific application should be determined.
Positive_Control: A431 cells. Placenta, Breast, Colon or Bladder Carcinoma.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Preservative
- Azide free
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Expiry Date
- 24 months
-
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Alternative Name
- EGFR
-
Background
-
ERBB1, HER1, mENA, PIG61, Proto-oncogene c-ErbB-1, Receptor Tyrosine Protein Kinase, ErbB1, Urogastrone
A431 cells. Placenta, Breast, Colon or Bladder Carcinoma.
-
Molecular Weight
- ~170kDa (wild type) and ~145kDa (vIII variant)
-
Gene ID
- 1956, 488293
-
UniProt
- P00533
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Target
-